+48.8%
AAOI vs MRNA
+909.7%
-860.8%
-79.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -20.9% | -6.5% | -14.3% | -20.9% |
| 7D | -40.8% | +8.4% | -49.2% | -40.7% |
| 30D | -64.0% | +28.8% | -92.8% | -63.8% |
| 3M | -63.5% | +329.2% | -392.8% | -63.2% |
| 6M | -74.0% | +416.9% | -491.0% | -75.6% |
| YTD | +34.5% | +718.8% | -684.3% | -3.7% |
| 1Y | +48.8% | +924.9% | -876.1% | -4.5% |
| All | +48.8% | +909.7% | -860.8% | -4.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling